dQ&A launched the beta of our next-gen AI Insights Platform—a breakthrough natural language solution providing instant, data-driven answers for the diabetes market.
Our quarterly U.S. survey shows diabetes sharply reduces productivity and daily-life capacity—evidence that employers must offer stronger support.
From a son’s T1D diagnosis to thousands of focus groups and ethnographies, discover the journey behind dQ&A’s qualitative insights service.
Since day one, dQ&A has elevated diabetes patient voices—explore our infographic to see how these insights have shaped client decisions over the years.
Our quarterly U.S. diabetes survey found one-third of respondents had mild or severe depression, underscoring the need for more support and better treatments.
Erik Shoger presented real-world patient insights at the FDA advisory meeting on sotagliflozin, highlighting the need for education and training if approved.
We invite you to watch this 4-minute selfie video reel featuring real people describing their very real struggles with diabetes.
Our research explores the connection between time-in-range and mental health in people with type 1 and type 2 diabetes.
Our research reveals low awareness of DKA and ketone testing among type 2 diabetes patients on SGLT2 inhibitors, highlighting urgent education needs.
